Patentus SA

Patentus SA

GGPW:PAT
1.94
PLN
+0.04
(+2.11%)
0.51EPS
7.10P/E
107.68MMarket Cap

Total Valuation

PLN

As of September 30, 2025, Patentus SA carries a market capitalization of 107.68M, placing it among publicly traded companies globally. Its enterprise value stands at 67.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap107.68M
Enterprise Value67.24M

Share Statistics

As of September 30, 2025, Patentus SA has 29.50M shares outstanding.

Shares Outstanding29.50M

Valuation Ratios

As of September 30, 2025, Patentus SA trades at a trailing price-to-earnings ratio of 7.10. The price-to-sales ratio is 0.95, and the price-to-book ratio stands at 0.65.

PE Ratio7.10
PS Ratio0.95
PB Ratio0.65
P/TBV Ratio0.66
P/FCF Ratio-2.06
P/OCF Ratio3.66

Enterprise Valuation

As of September 30, 2025, Patentus SA trades at an EV/EBITDA multiple of 3.06 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 5.64 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 67.24M versus a market cap of 107.68M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.60
EV / EBITDA3.06
EV / EBIT5.64

Financial Position

As of September 30, 2025, Patentus SA maintains a current ratio of 7.43, meaning it holds 7.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.47, indicating elevated leverage, while an interest coverage ratio of 73.41 demonstrates strong ability to service its debt obligations.

Current Ratio7.43
Quick Ratio3.66
Debt / Equity2.47
Debt / EBITDA0.19
Interest Coverage73.41

Financial Efficiency

PLN

Over the twelve months ended September 30, 2025, Patentus SA posted a return on equity (ROE) of 9.24, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.75 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.45, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.12, useful for judging operating efficiency across full business cycles. The company generates approximately 835,970.37 in revenue per employee across its workforce of 135.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.42 indicates how many times Patentus SA sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)9.24
Return on Assets (ROA)7.45
Return on Invested Capital (ROIC)6.75
Return on Capital Employed (ROCE)9.12
Revenue Per Employee835,970.37
Employee Count135.00
Inventory Turnover2.42

Taxes

PLN

Over the twelve months ended September 30, 2025, Patentus SA recorded 238,000.00 in income tax expense. That works out to an effective tax rate of 1.56, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 15.25M, leaving 15.16M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax238,000.00
Effective Tax Rate1.56

Stock Price Statistics

PLN

As of the close on October 22, 2026, Patentus SA's stock has declined approximately 46.70% over the past 52 weeks. The 50-day moving average sits at 2.07, while the 200-day moving average is 2.72.

52-Week Price Change-46.70%
50-Day Moving Average2.07
200-Day Moving Average2.72

Income Statement

PLN

Over the twelve months ended September 30, 2025, Patentus SA generated 112.86M in revenue and converted that into 15.16M in net income, yielding earnings per share of 0.51. EBITDA reached 21.95M, while operating income came in at 11.75M.

Revenue112.86M
Gross Profit22.56M
Operating Income11.75M
Pretax Income15.25M
Net Income15.16M
EBITDA21.95M
EBIT11.92M
Earnings Per Share (EPS)0.51

Balance Sheet

PLN

As of September 30, 2025, Patentus SA holds 45.35M in cash and equivalents against 4.14M in total debt, resulting in a net debt position of 746,000.00. Total book value stands at 166.85M, with working capital of 79.82M providing operational flexibility.

Cash & Cash Equivalents45.35M
Total Debt4.14M
Net Debt746,000.00
Equity (Book Value)166.85M
Book Value Per Share5.66
Working Capital79.82M

Cash Flow

PLN

Patentus SA produced 29.40M in operating cash flow over the twelve months ended September 30, 2025. After subtracting -81.78M in capital expenditures, free cash flow totaled -52.38M - equivalent to -1.78 per share.

Operating Cash Flow29.40M
Capital Expenditures-81.78M
Free Cash Flow-52.38M
FCF Per Share-1.78

Margins

Over the twelve months ended September 30, 2025, Patentus SA posted a gross margin of 19.99, reflecting its pricing power and cost economics. The operating margin of 10.41 and net profit margin of 13.43 provide insight into operational efficiency.

Gross Margin19.99
Operating Margin10.41
Pretax Margin13.51
Profit Margin13.43
EBITDA Margin19.45

Dividends & Yields

These figures cover the twelve months ended September 30, 2025. Free cash flow yield is negative at -48.65: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 1.00, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Patentus SA shareholders.

Shareholder Yield1.00
FCF Yield-48.65

Scores

As of September 30, 2025, Patentus SA has an Altman Z-Score of 4.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.69